Interleukin-2, Interleukin-15, and Their Receptors

References

• Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 1990; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Sato N., Miyajima A. Multimeric cytokine receptors: Common versus specific functions. Curr. Opin. Cell Biol. 1994; 6: 174–179
   PubMed Web of Science ®Google Scholar
• Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell 1994; 76: 253–262
   PubMed Web of Science ®Google Scholar
• Kondo M., Takeshita T., Ishii N., Nakamura M., Watanabe S., Arai K.-I., Sugamura K. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 1993; 262: 1874–1877
   PubMed Web of Science ®Google Scholar
• Noguchi M., Nakamura Y., Russell S. M., Ziegler S. F., Tsang M., Cao X., Leonard W. J. Interleukin 2 receptor 7 chain: A functional component of the interleukin-7 receptor. Science 1993; 262: 1877–1880
   PubMed Web of Science ®Google Scholar
• Schorle H., Holtschke T., Hünig T., Schimpl A., Horak I. Development and function of T-cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991; 352: 621–624
   PubMed Web of Science ®Google Scholar
• Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147–157
   PubMed Web of Science ®Google Scholar
• Burton J. D., Bamford R. N., Peters C., Grant A. J., Kurys G., Goldman C. K., Brennan J., Roessler E., Waldmann T. A. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994; 91: 4935–4939
   PubMed Web of Science ®Google Scholar
• Bamford R. N., Grant A. J., Burton J. D., Peters C., Kurys G., Goldman C. K., Brennan J., Roessler E., Waldmann T. A. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994; 91: 4940–4944
   PubMed Web of Science ®Google Scholar
• Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M., Johnson L., Alderson M. R., Watson J. D., Anderson D. M., Giri J. G. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994; 264: 965–968
   PubMed Web of Science ®Google Scholar
• Giri J. G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L. S., Cosman D., Anderson D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994; 13: 2822–2830
   PubMed Web of Science ®Google Scholar
• Fraser J. D., Irving B. A., Crabtree G. R., Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 251: 313–316
   PubMed Web of Science ®Google Scholar
• Lindstein T., June C. H., Ledbetter J. A., Steib G., Thompson C. B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989; 244: 339–345
   PubMed Web of Science ®Google Scholar
• Bamford R. N., Battiata A. P., Burton J. D., Sharma H., Waldmann T. A. IL-15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus Type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA 1996; 93: 2897–2902
   PubMed Web of Science ®Google Scholar
• Tagaya Y., Bamford R. N., DeFilippis A. P., Waldmann T. A. IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996; 4: 329–336
   PubMed Web of Science ®Google Scholar
• Tagaya Y., Buton J. D., Miyamoto Y., Waldmann T. A. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 1996; 15: 4928–4939
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. The interleukin-2 receptor. J. Biol. Chem. 1991; 266: 2681–2684
   PubMed Web of Science ®Google Scholar
• Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: A current overview. Cell 1993; 73: 5–8
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. 1992 Stohlman memorial lecture: targeting IL-2 receptor. Leukemia 1993; 7(Suppl. 2)S151–S156
   Google Scholar
• Goldsmith M. A., Greene W. C. Interleukin-2 and the interleukin-2 receptor. The Cytokine Handbook, 2nd ed., A. W. Thomson. The Academic Press, London 1994; 57–80
   Google Scholar
• Robb R. J., Kutny R. M., Chowdhry V. Purification and partial sequence analysis of human T-cell growth factor. Proc. Natl. Acad. Sci. USA 1983; 80: 5990–5994
   PubMed Web of Science ®Google Scholar
• Seigel L. J., Harper M. E., Wong S. F., Gallo R. C., Nash W. G., O'Brien S. J. Gene for T-cell growth factor: Location on human chromosome 4q and Feline chromosome BI. Science 1984; 223: 175–178
   PubMed Web of Science ®Google Scholar
• Anderson D. M., Johnson L., Glaccum M. B., Copeland N. G., Gilbert D. J., Jenkins N. A., Valentine V., Kirstein M. N., Shapiro D. N., Morris S. W., Grabstein K., Cosman D. Chromosomal assignment and genomic structure of Il 15. Genomics 1995; 25: 701–706
   PubMed Web of Science ®Google Scholar
• Crabtree G. R. Contingent genetic events in T lymphocyte activation. Science 1989; 243: 355–361
   PubMed Web of Science ®Google Scholar
• Muegge K., Durum S. K. From cell code to gene code: Cytokines and transcription factors. New Biol. 1989; 1: 239–251
   PubMedGoogle Scholar
• Bamford R. N., Battiata A. P., Waldmann T. A. IL-15: The role of translational regulation in their expression. J. Leukocyte Biol. 1996; 59: 476–480
   PubMed Web of Science ®Google Scholar
• Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659–667
   PubMed Web of Science ®Google Scholar
• Flamand L., Stefanescu I., Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest. 1996; 97: 1373–1381
   PubMed Web of Science ®Google Scholar
• Carson W. E., Ross M. E., Baiocchi R. A., Marien M. J., Boiani N., Grabstein K., Caligiuri M. A. Endogenous production of interleukin 15 by activated monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 1995; 96: 2578–2582
   PubMed Web of Science ®Google Scholar
• Doherty T. M., Seder R. A., Sher A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 1996; 156: 735–741
   PubMed Web of Science ®Google Scholar
• Nishimura H., Hiromatsu K., Kobyashi N., Grabstein K. H., Paxton R., Sugamura K., Bluestone J. A., Yoshikai Y. IL-15 is a novel growth factor for murine γδ T cells induced by Salmonella infection. J. Immunol. 1996; 156: 663–669
   PubMed Web of Science ®Google Scholar
• Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acid Res. 1987; 15: 8125–8148
   PubMed Web of Science ®Google Scholar
• Kozak M. An analysis of vertebrate mRNA sequences: Intimations of translational control. J. Cell Biol. 1991; 115: 887–903
   PubMed Web of Science ®Google Scholar
• Kozak M. A consideration of alternative models for the initiation of translation in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 1992; 27: 385–402
   PubMed Web of Science ®Google Scholar
• Weinberg A. D., Swain S. L. IL-2 receptor (Tac antigen) protein expression is down-regulated by the 5′-untranslated region of the mRNA. J. Immunol. 1990; 144: 4712–4720
   PubMed Web of Science ®Google Scholar
• Bamford R. N., DeFilippis A. P., Waldmann T. A. (1996) Elements of the 5′ UTR signal peptide and 3′ coding sequence of IL-15 participate post-transcriptional regulation. Late-breaking abstract (LB167). FASEB joint meetings. 1996. New Orleans
   Google Scholar
• Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac+ cells. J. Immunol. 1981; 126: 1393–1397
   PubMed Web of Science ®Google Scholar
• Leonard W. J., Depper J. M., Crabtree G. R., Rudikoff S., Pumphrey J., Robb R. J., Kronke M., Svetlik P. B., Peffer N. J., Waldmann T. A., Greene W. C. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 1984; 311: 626–630
   PubMed Web of Science ®Google Scholar
• Tsudo M., Kozak R. W., Goldman C. K., Waldmann T. A. Demonstration of a non-Tac peptide that binds interleukin-2: A potential participant in a multichain interleukin-2 receptor complex. Proc. Natl. Acad. Sci. USA 1986; 83: 9694–9698
   PubMed Web of Science ®Google Scholar
• Hatakeyama M., Tsudo M., Minamoto S., Kono T., Doi T., Miyata T., Miyasaka M., Taniguchi T. Interleukin-2 receptor β chain gene: Generation of three receptor forms by cloned human α and β chain cDNAs. Science 1989; 244: 551–556
   PubMed Web of Science ®Google Scholar
• Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the γ chain of the human IL-2 receptor. Science 1992; 257: 379–382
   PubMed Web of Science ®Google Scholar
• Giri J. G., Kumaki S., Ahdieh M., Friend D. J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L. S., Anderson D. M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 1995; 14: 3654–3663
   PubMed Web of Science ®Google Scholar
• Anderson D. M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomis A., Giri J., Copeland N. G., Gilbert D. J., Jenkins N. A., Valentine V., Shapiro D. N., Morris S. W., Park L. S., Cosman D. Functional characterization of human interleukin 15Rα chain and close linkage of Il 15RA and Il2RA genes. J. Biol. Chem. 1995; 270: 29862–29869
   PubMed Web of Science ®Google Scholar
• Witthuhn B. A., Silvennoinen O., Miura O., Lai K. S., Cwik C., Liu E. T., Ihle J. N. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 1994; 270: 153–157
   Google Scholar
• Johnston J. A., Bacon C. M., Finbloom D. S., Rees R. C., Kaplan D., Shibuya K., Ortaldo J. R., Gupta S., Chen Y. Q., Giri J. D., O'Shea J. J. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 1995; 92: 8705–8709
   PubMed Web of Science ®Google Scholar
• Miyazaki T., Liu Z.-J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., Barsoumian E. L., Perlmutter R. M., Taniguchi T. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 1995; 81: 223–231
   PubMed Web of Science ®Google Scholar
• Lin J.-X., Migone T.-S., Tsang M., Friedmann M., Weatherbee J. A., Zhou L., Yamauchi A., Bloom E. T., Meitz J., John S., Leonard W. J. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995; 2: 331–339
   PubMed Web of Science ®Google Scholar
• Wilkinson P. C., Liew F. Y. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. Med. 1995; 181: 1255–1259
   PubMed Web of Science ®Google Scholar
• McInnes I. B., Ai-Mughales J., Field M., Leung B. P., Huang F.-P., Dixon R., Sturrock R. D., Wilkinson P. C., Liew F. Y. The role of interleukin 15 in T-cell migration and activation in rheumatoid arthritis. Nature Med. 1996; 2: 175–182
   PubMed Web of Science ®Google Scholar
• Carson W. E., Giri J. G., Lindermann M. J., Linett M. L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caligiuri M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the Il-2 receptor. J. Exp. Med. 1994; 180: 1395–1403
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Macduff B. M., Eisenman J., Paxton R., Grabstein K. H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 1995; 154: 483–490
   PubMed Web of Science ®Google Scholar
• Sadlack B., Merz H., Schorle H., Schimpl A., Feller A. C., Horak I. Ulcerative cholitis-like disease in mice with disrupted interleukin-2 gene. Cell 1993; 75: 253–261
   PubMed Web of Science ®Google Scholar
• Willerford D. M., Chen J. Z., Ferry J. A., Davidson L., Ma A., Alt F. W. Interleukin-2 receptor-alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3: 521–530
   PubMed Web of Science ®Google Scholar
• Suzuki H., Kündig T. M., Furlonger C., Wakeham A., Timms E., Matsuyama T., Schmits R., Simard J. J. L., Ohashi P. S., Griesser H., Taniguchi T., Paige C. J., Mak T. W. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 1995; 268: 1472–1476
   PubMed Web of Science ®Google Scholar
• Lenardo M. J., Boehme S., Chen L., Combadiere B., Fisher G., Freedman M., McFarand N., Pelfrey C., Zheng L. Autocrine feedback death and the regulation of mature T lymphocyte antigen responses. Intern. Rev. Immunol. 1995; 13: 114–134
   Google Scholar
• Lenardo M. J. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991; 353: 858–861
   PubMed Web of Science ®Google Scholar
• Wang R., Rogers A. M., Rush B. J., Russell J. H. Induction of sensitivity to activation-induced death in primary CD4+ cells: A role for interleukin-2 in the negative regulation of responses by mature CD4+ cells. European J. Immunol. 1996; 26: 2263–2270
   PubMed Web of Science ®Google Scholar
• Kabelitz D., Pohl T., Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 1993; 14: 338–339
   PubMedGoogle Scholar
• Quinn L. S., Haugk K. L., Grabstein K. H. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 1995; 136: 3669–3672
   PubMed Web of Science ®Google Scholar
• Agostmi C., Trentin L., Facco M., Sancetta R., Ceratti A., Tassinari C., Cimarosto L., Adami F., Cipriani A., Zambello R., Semenzato G. Role of IL-15, IL-2 and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 1996; 157: 910–918
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Goldman C., Top L., Grant A., Burton J., Bamford R., Roessler E., Horak I., Zaknoen S., Kasten-Sportes C., White J., England R., Horak E., Martinucci J., Tinubu S. A., Mishra B., Junghans R., Dipre M., Carrasquillo J., Ryenolds J., Gansow O., Nelson D. The interleukin-2 receptor: A target for immunotherapy. Ann. NY Acad. Sci. 1993; 685: 603–610
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., White J. D., Carrasquillo J. A., Reynolds J. C., Paik C. H., Gansow O. A., Brechbiel M. W., Jaffe E. S., Fleisher T. A., Goldman C. K., Top L. E., Bamford R., Zaknoen S., Roessler E., Kasten-Sportes C., England R., Litou H., Johnson J. A., Jackson-White T., Manns A., Hanchard B., Junghans R. P., Nelson D. L. Radio-immunotherapy of interleukin-2Rα-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac. Blood 1995; 86: 4063–4075
   PubMed Web of Science ®Google Scholar
• Tsudo M., Kitamura F., Miyasaka M. Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1989; 86: 1982–1986
   PubMed Web of Science ®Google Scholar
• Tsudo M., Goldman C. K., Bongivanni K. F., Chang W. C., Winton E. F., Yagita M., Grim E. A., Waldmann T. A. The P75 peptide is a receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc. Natl. Acad. Sci. USA 1987; 84: 5391–5398
   Web of Science ®Google Scholar
• Yoon H. J., Sugamura K., Loughran T. P., Jr. Activation of leukemic large granular lymphocytes by interleukin-2 via p75 interleukin-2 receptor. Leukemia 1990; 4: 848–850
   PubMed Web of Science ®Google Scholar
• Thomis D. C., Gurniak C. B., Tivol E., Scharpe A. H., Berg L. J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995; 270: 794–797
   PubMed Web of Science ®Google Scholar
• Nosaka T., van Deursen J. M. A., Tripp R. A., Thierfelder W. E., Witthuhn B. A., McMickle A. P., Doherty P. C., Grosveld G. C., Ihle J. N. Defective lymphoid development in mice lacking Jak3. Science 1995; 270: 800–802
   PubMed Web of Science ®Google Scholar
• Russel S. M., Tayebi N., Nakajima H., Riedy M. C., Roberts J. L., Aman M. J., Migone T.-S., Nogouchi M., Markert N. L., Buckley R. H., O'Shea J. J., Leonard W. J. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 70: 797–800
   Google Scholar
• Macchi P., Villa A., Gillani S., Sacco M. G., Frattini A., Porta F., Ugazlo A. G., Johnston J. A., Candotti F., O'Shea J. J., Vessoni P., Notaragelo L. D. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377: 65–68
   PubMed Web of Science ®Google Scholar